Beijing, China

Yuanpeng Zheng

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Jinan University. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuanpeng Zheng. Retrieved from https://idiyas.com/inventor/yuanpeng-zheng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Yuanpeng Zheng: Pioneering Alzheimer’s Research

Introduction

Yuanpeng Zheng, an inventive scientist based in Beijing, China, has made significant contributions in the field of pharmaceutical formulations, particularly focusing on the prevention and treatment of Alzheimer's disease. With a current patent portfolio that showcases his innovative contributions, Zheng stands out in research for his unique approach using traditional Chinese herbs.

Latest Patents

Yuanpeng Zheng holds a patent for a series of crocins compounds derived from the Chinese herb Ellis. This groundbreaking patent outlines the pharmacological applications of these compounds, which demonstrate potential in the prevention and treatment of Alzheimer's disease. The innovative research focuses on countering oxidative injury linked to hydrogen peroxide and excitatory amino acid injury caused by L-glutamic acid. Through in-vitro cell experiments, the crocins compounds were shown to significantly reduce cell injury caused by these harmful agents, indicating promising implications for Alzheimer's therapies.

Career Highlights

Zheng’s professional journey is anchored at Jinan University, where he engages in cutting-edge research that bridges traditional medicinal practices with modern scientific applications. His dedication to Alzheimer's research emphasizes the critical role of combating oxidative stress and excitatory amino acids, highlighting his status as an inventor committed to healthcare advancements.

Collaborations

Throughout his career, Yuanpeng Zheng has collaborated with fellow researchers Xinsheng Yao and Yang Yu. Their collective expertise has enhanced the scope and depth of their innovative projects, fostering a collaborative environment that accelerates the development of effective treatments in neurodegenerative diseases.

Conclusion

Yuanpeng Zheng’s work exemplifies the intersection of tradition and innovation in pharmaceutical research. His patented crocins compounds not only provide hope for Alzheimer's disease prevention and treatment but also illustrate the potential of leveraging traditional herbology in modern science. As his research continues to evolve, it holds the promise of impactful advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…